Related Experiment Videos

Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course

Insights

In severe acute pancreatitis, alpha 2-macroglobulin (alpha 2-M) levels and trypsin-binding capacity decrease significantly. These biochemical changes correlate with disease severity and may indicate complement and kinin system activation.

Area of Science:

  • Biochemistry
  • Clinical Medicine
  • Pathophysiology

Background:

  • Acute pancreatitis is a serious condition with complex biochemical alterations.
  • Understanding the role of protease inhibitors is crucial for assessing disease severity.

Purpose of the Study:

  • To analyze the clinical and biochemical changes during acute pancreatitis attacks.
  • To investigate the behavior of protease inhibitors and their correlation with disease severity.

Main Methods:

  • Clinical and biochemical analysis of 27 acute pancreatitis attacks.
  • Measurement of alpha 2-macroglobulin (alpha 2-M), inter-alpha-trypsin inhibitor, alpha 1-proteinase inhibitor, antichymotrypsin, and pancreatic secretory trypsin inhibitor.
  • Correlation with Ranson's and McMahon's classification systems.

Main Results:

  • Severe attacks showed decreased alpha 2-M levels (<40% of normal) and reduced trypsin-binding capacity.
  • Decreased inter-alpha-trypsin inhibitor and increased alpha 1-proteinase inhibitor, antichymotrypsin, and pancreatic secretory trypsin inhibitor were observed.
  • Biochemical changes were most pronounced in peritoneal fluid and correlated with disease severity and clinical complications.

Conclusions:

  • Profound biochemical changes, particularly in protease inhibitor profiles, occur in severe acute pancreatitis.
  • Low alpha 2-M concentrations in severe attacks may facilitate complement and kinin system activation.
  • These findings highlight the potential for using protease inhibitor levels as biomarkers for acute pancreatitis severity.

Related Concept Videos